Kanbis®
Antiepileptic agent Indicated for the treatment of seizures associated with Lennox-Gastaut syndrome (LGS) or Dravet syndrome (DS) in 2-year old patients and older.
Therapeutic Area
Antiepileptic agent
Active Ingredient
Cannabidiol
Line
Neurosciences
Dosage forms:
Oral solution 100 mg/mL in bottles of 30 mL and y 100 mL
